abrdn Life Sciences Investors
HQL
86 hedge funds and large institutions have $135M invested in abrdn Life Sciences Investors in 2026 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 17 reducing their positions, and 3 closing their positions.
500% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 3
135% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 17
18% more funds holding
Funds holding: 73 → 86 (+13)
1.71% less ownership
Funds ownership: 30.44% → 28.73% (-1.7%)
8% less capital invested
Capital invested by funds: $147M → $135M (-$12.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$6.79M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$2.21M |
| 3 |
Raymond James Financial
St Petersburg,
Florida
|
+$1.07M |
| 4 |
AIA
Absolute Investment Advisers
Rosemary Beach,
Florida
|
+$598K |
| 5 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
+$567K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$19.6M |
| 2 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$1.16M |
| 3 |
PCM
Penserra Capital Management
Orinda,
California
|
-$1.14M |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$999K |
| 5 |
SFS
Shaker Financial Services
Arlington,
Virginia
|
-$689K |
HQL Hedge Fund Activity: Q1 2026 in Review
86 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2026, worth a combined $135M — down 8.3% from $147M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new HQL positions and 3 closed out — a net gain of 15 holders — while 40 added to existing stakes and 17 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $6.79M. The largest seller was Saba Capital Management, cutting an estimated $19.6M.
- 86 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2026, up from 73 in Q4 2025.
- Funds reported $135M of abrdn Life Sciences Investors stock for Q1 2026, down 8.3% quarter-over-quarter.
- 18 funds opened new abrdn Life Sciences Investors positions in Q1 2026 and 3 closed out, a net change of +15 holders.
- The largest abrdn Life Sciences Investors buyer in Q1 2026 was Morgan Stanley, an estimated $6.79M added.
- The largest abrdn Life Sciences Investors seller in Q1 2026 was Saba Capital Management, an estimated $19.6M sold.
Based on aggregated 13F filings for Q1 2026.